‘We have the product in hand:’ Israel will bergin human trials with COVID-19 Vaccine in October

August 6, 2020 by Aryeh Savir - TPS
Read on for article

The Israel Institute for Biological Research (IIBR) in Ness Ziona has made further progress toward a Coronavirus (COVID-19) vaccine and will commence trials on humans after the New Year holidays, in October.

Infographic of the Coronavirus. Feb 22, 2020. Photo by Kobi Richter/TPS

Minister of Defence Benny Gantz visited the Biological Institute on Thursday together with the director of the institute Prof. Shmuel Shapira and learned of the advances in the development of the Corona vaccine and antibody.

“Experiments on humans should begin after the Tishrei holidays,” Gantz declared.

“All the first experiments have been successful and are great news and a very big hope,” he added.

“Just as the IDF has special units that break in and pave the way for it – you are the Special Forces of the State of Israel in the field of vaccines,” he stated after the visit.

Shapira recounted how the IIBR set off six months ago to find a vaccine and now “there is an excellent vaccine. We start after the holidays with safety and efficacy experiments, but we have the product in hand.”

Vaccine tests on golden Syrian hamsters showed that a serum they have developed is effective, paving the way for tests on humans.

In May, the IIBR officially announced that it had completed the patent registration for eight Coronavirus antibodies, another significant step towards the production of a cure for the pandemic.

To date, some 19,006,000 Coronavirus cases have been registered worldwide in 213 countries, with over 711,900 deaths and some 12,192,000 recoveries.

Speak Your Mind

Comments received without a full name will not be considered
Email addresses are NEVER published! All comments are moderated. J-Wire will publish considered comments by people who provide a real name and email address. Comments that are abusive, rude, defamatory or which contain offensive language will not be published

Got something to say about this?

This site uses Akismet to reduce spam. Learn how your comment data is processed.